News
AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...
AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...
Guidance AstraZeneca reiterates its Total Revenue and Core EPS guidance 5 for FY 2025 at CER, based on the average foreign exchange rates through 2024.
British drugmaker AstraZeneca has appointed a new China head, replacing a former executive who has been detained by authorities in the country. Iskra Reic, who oversaw the development of the firm ...
Drugmakers Pfizer (Zoton), Takeda (Somac), Janssen (Pariet), AstraZeneca (Nexium and Nexium 24HR) and Pharmaco (Losec) have been contacted for comment.
Bloomberg / Contributor / Getty Images A breast cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping patients live longer than with chemotherapy in a ...
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival (OS) in a phase 3 trial. The latest miss happened in breast cancer, a ...
Add articles to your saved list and come back to them any time. Over-the-counter medications for heartburn, reflux and morning sickness are at the centre of a class action investigation over ...
The Shine Lawyers investigation will encompass a range of PPI drugs, including Nexium and Nexium 24HR (or other drugs containing esomeprazole ... breaches of guarantee and/or negligence by the ...
Since 2021, Dentsu Creative U.S. has served as the lead digital and social agency for Haleon brands Tums, Preparation H, Nexium 24HR and Emergen-C ... The Haleon/Merkle news comes just over a week ...
Marcus Brandt / picture alliance via Getty Images AstraZeneca announced plans Tuesday for a “new era of growth" with 75% revenue growth and 20 new drug launches by 2030. The pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results